Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain)
| Autor: | Lluís Salleras, Josep Costa, Antoni Plasència, Angela Domínguez, P. Plans, Neus Cardeñosa, Nuria Torner |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male Microbiology (medical) Herpesvirus 3 Human medicine.medical_specialty Adolescent Immunology Population Antibodies Viral medicine.disease_cause Serology Chickenpox Seroepidemiologic Studies Epidemiology Prevalence medicine Humans Immunology and Allergy Seroprevalence Young adult Child education Aged education.field_of_study business.industry Varicella zoster virus General Medicine Middle Aged medicine.disease Vaccination Spain Child Preschool Immunoglobulin G Female business Demography |
| Zdroj: | Medical Microbiology and Immunology. 197:329-333 |
| ISSN: | 1432-1831 0300-8584 |
| DOI: | 10.1007/s00430-007-0064-z |
| Popis: | The aim of this study was to determine the prevalence of varicella IgG antibodies in the population of Catalonia, and the variables associated. The study was carried out in 2002 in a representative sample of juvenile (5-14 years) and adult population (> or =15 years) of Catalonia (Spain). The global prevalence determined by ELISA test was 95.5% (95% CI 94.7-96.3). The prevalence increased with age, from 82% (95% CI 77.0-87.0) in the 5-9 years age up to 99.4% (95% CI 98.2-100) in >64 years of age. No statistically significant differences in the seroprevalence according to the sociodemographic variables were observed. The current strategy of vaccinating preadolescents at 12 years of age who have not suffered the disease will require more than 30 years to cover the current gap immunity in adolescents and young adults. Vaccination with two doses of vaccine for all adolescents and adults < or = 50 years who report not having suffered the disease during childhood should be considered. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink